Source: Cision Canada

Press Release: OpSens : OPSENS' SHAREHOLDERS APPROVE ARRANGEMENT WITH HAEMONETICS

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

Read full article »
Annual Revenue
$25-100M
Employees
250-500
Louis Laflamme's photo - President & CEO of OpSens

President & CEO

Louis Laflamme

CEO Approval Rating

77/100

Read more